|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项 ; d: y' \% c" S! K1 `3 _) M: t
01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.& ]6 R$ v: x: m) b% j5 p. y9 C a
02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor./ z% r! @9 b5 s. Y8 D
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.
' p) _' @" @8 K+ Z+ u4 a D04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.; O8 c* p& T( u, b8 o+ Q- D
05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.
0 I+ u5 }8 L& E" ]7 u; B- f7 t06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.; m8 Y" B0 Z* T/ n& N
07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.* w% Q) X; I" }! H3 z: c$ g
08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.5 u! N$ V. {) c9 i! ]
09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
4 _5 q2 m0 X2 p& h# H10.Interpretable machine learning for prostate biopsy: Cohort study.
" c' L# z$ l8 h1 |11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.' w; s2 l$ F4 h$ V
12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.
- H& P: b5 @8 s3 U0 U( N13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).
9 x _ A$ P7 X2 H" A; t @14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).8 T- k" A6 m9 D- o1 L
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.
! m/ F0 f6 w, e& s- v' l/ t& d$ |% a16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.& \% J, D* m7 d7 j* ?. c* f, X% o
17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.8 P( K' m. l4 P
18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.- i8 p# O3 e/ i
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.
9 Q1 O6 N4 H0 x- Y20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.' I; P d6 \" k7 t" J3 u
21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.; f* L( u* C4 i& {" `4 L# d. j
22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.# H, q3 n1 {# V) v' X
23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.9 Y& ]9 z: C9 |* Z* Q( c# y: |. P3 b
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.
@+ l; Q# Z ^% `6 M D25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.6 I, I$ ~9 t) e
|
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
